Meeting
2017 Gastrointestinal Cancers Symposium
Parallel sequencing of a 50 genes panel in metastatic colorectal cancer (MCRC) patients (pts) treated with intensive first-line FIr-B/FOx triplet chemotherapy plus bevacizumab (BEV): Preliminary data and clinical outcome.
Authors
Gemma Bruera
Oncology Network ASL1 Abruzzo, Oncology Territorial Care, S. Salvatore Hospital, ASL1 Abruzzo, University of L'Aquila, L'aquila, Italy
Gemma Bruera , Umberto Malapelle , Francesco Pepe , Pasquale Pisapia , Antonella Dal Mas , Giuseppe Calvisi , Giancarlo Troncone , Enrico Ricevuto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 644)
DOI
10.1200/JCO.2017.35.4_suppl.644
Abstract #
644
Poster Bd #
F18
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2014 ASCO Annual Meeting
Molecular evaluation of primary tumor (PT) and synchronous liver metastasis in colorectal cancer (srLmCRC) patients after cetuximab-based chemotherapy.
First Author: Daniela Adua
Poster
2015 ASCO Annual Meeting
Measuring the impact of Next Generation Sequencing (NGS) technique implementation in metastatic colorectal cancer (mCRC) drug development program.
First Author: Carolina Ortiz
Poster
2019 Gastrointestinal Cancers Symposium
Genomic alterations in appendiceal carcinoma using circulating DNA.
First Author: Walid Labib Shaib